TMAM
MRNA icon

Tokio Marine Asset Management’s Moderna MRNA Stock Holding History

Tokio Marine Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,358
Closed -$407K – 564
2025
Q1 		$407K Buy
14,358
+1,859
+15% +$66K 0.01% 516
2024
Q4 		$520K Buy
12,499
+1,715
+16% +$82K 0.02% 473
2024
Q3 		$721K Buy
10,784
+1,387
+15% +$127K 0.03% 368
2024
Q2 		$1.12M Buy
9,397
+339
+4% +$42.9K 0.05% 255
2024
Q1 		$965K Sell
9,058
-947
-9% -$95.5K 0.05% 279
2023
Q4 		$995K Buy
10,005
+1,792
+22% +$151K 0.05% 242
2023
Q3 		$848K Sell
8,213
-176
-2% -$19.6K 0.05% 247
2023
Q2 		$1.02M Buy
8,389
+623
+8% +$83.1K 0.07% 202
2023
Q1 		$1.19M Buy
7,766
+745
+11% +$123K 0.08% 174
2022
Q4 		$1.26M Buy
7,021
+377
+6% +$61.6K 0.1% 160
2022
Q3 		$786K Buy
6,644
+250
+4% +$37.9K 0.07% 189
2022
Q2 		$913K Buy
6,394
+733
+13% +$105K 0.08% 169
2022
Q1 		$975K Buy
5,661
+778
+16% +$131K 0.08% 161
2021
Q4 		$1.24M Buy
4,883
+278
+6% +$81.3K 0.1% 137
2021
Q3 		$1.77M Sell
4,605
-3,941
-46% -$1.45M 0.16% 91
2021
Q2 		$2.01M Sell
8,546
-1,250
-13% -$223K 0.18% 69
2021
Q1 		$1.28M Buy
9,796
+7,848
+403% +$1.14M 0.13% 94
2020
Q4 		$204K Buy
+1,948
New +$197K 0.02% 336

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Tokio Marine Asset Management's MRNA Position: Q2 2025 in Review

Tokio Marine Asset Management sold out of Moderna (MRNA) in Q2 2025, closing a stake of 14,358 shares — an estimated $407K sold.

Tokio Marine Asset Management first reported a position in MRNA in Q4 2020 and held it in 18 quarters. The position peaked at $2.01M in Q2 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Tokio Marine Asset Management reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Tokio Marine Asset Management sold 14,358 Moderna shares in Q2 2025, an estimated $407K.
  • Tokio Marine Asset Management first reported a position in Moderna in Q4 2020 and held it in 18 quarters.
  • Tokio Marine Asset Management's Moderna position peaked at $2.01M in Q2 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Tokio Marine Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.